CATALAYER NEWS

Earnings roundup: Amgen vs. FDA, Pfizer’s defense and Merck’s $70B-in-sales plan - BioPharma Dive

Source: BioPharma Dive · 2026-02-04

Full article text is available in the Catalayer news terminal.

RELATED ON CATALAYER
Mentioned Tickers
$PFE · Pfizer$MRK · Merck$AMGN · Amgen
Related Topics
Earnings Season NewsBiotech & FDA News
RELATED MARKETS
Prediction Markets
Xi Jinping out before 2027?4%Will Gavin Newsom win the 2028 Democratic presidential nomination?13%Will Alexandria Ocasio-Cortez win the 2028 Democratic presidential nomination?18%
Open Catalayer terminal for live tracking →